乌帕替尼中间体 基本信息
| 中文名称 | 乌帕替尼中间体 |
|---|---|
| 中文同义词 | (3R,4S)-4-乙基-1,3-吡咯烷二甲酸 1-(苯基甲基)酯与(ALPHAR)-ALPHA-甲基-1-萘甲胺的化合物;(R)-1-(萘-1-基)乙胺 (3R,4S)-1-(苄氧基羰基)-4-乙基吡咯烷-3-羧酸;N-CBZ-(3R,4S)-4-乙基-1,3-吡咯烷二甲酸;(3R,4S)-1-[(苄氧基)羰 基]-4-乙基吡咯烷-3-羧酸;乌帕替尼杂质2 (R)-(+)-α-(1-萘基)乙胺盐 |
| 英文名称 | (3R,4S)-1-[(benzyloxy)carbonyl]-4-ethylpyrrolidine-3-carboxylic acid |
| 英文同义词 | (3R,4S)-1-[(benzyloxy)carbonyl]-4-ethylpyrrolidine-3-carboxylic acid;(3R,4S)-4-Ethyl-1,3-pyrrolidinedicarboxylic acid 1-(phenylmethyl) ester (alphaR)-alpha-methyl-1-naphthalenemethanamine;(R)-1-(naphthalen-1-yl)ethanamine (3r,4s)-1-(benzyloxycarbonyl)-4-ethylpyrrolidine-3-carboxylate;benzyl (3S,4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate;(E/Z)-9-Hydroxy-5,9-dimethyldec-4-enal;Upadacitinib Impurity 23;Olutasidenib Impurity 27;Upadacitinib Impurity 2 (R)-(+)-α-(1-Naphthyl)ethylamine Salt |
| CAS号 | 1428243-25-7 |
| 分子式 | C15H19NO4 |
| 分子量 | 277.31566 |
| EINECS号 | |
| 相关类别 | 吡咯类 |
| Mol文件 | 1428243-25-7.mol |
| 结构式 |  |